Pharmaceuticals

AstraZeneca, Merck & Co to in phase 1 cancer drug research

01 Jun 2009

Daiichi Sankyo to raise $3 billion in bonds to repay Ranbaxy’s acquisition loan

01 Jun 2009

Ranbaxy holds breath as FDA scrutinises corrective action plan

30 May 2009

Skyepharma's new asthma drug `Flutiform, accepted for FDA review

27 May 2009

Ranbaxy acquires rights for Ochoa Labs’ skincare products

22 May 2009

Merck plans buy-back of 35 per cent equity at Rs435 a share

20 May 2009

Biovail buys Cambridge Lab’s Huntington's disease drug

19 May 2009

Piramal Life Sciences gets regulatory nod for studies on cancer molecule

13 May 2009

Lupin reaches settlement with Wyeth on patented drug

13 May 2009

India gears up to mass-produce H1N1 flu vaccine

13 May 2009

The centre plans to ask the WHO and the Centre for Disease Control, for seed stock for Indian companies to develop the technology to create the H1N1 vaccine

Biocon's Kiran Mazumdar Shaw to receive Nikkei Asia Prize

11 May 2009

Shaw was nominated for her pioneering work in biotechnology in India, by establishing a business model that focuses on innovation and intellectual excellence, and her achievements as a first generation entrepreneur

Aurobindo gets Australian nod for cholesterol pills

11 May 2009

Wockhardt to hive off animal health care business

07 May 2009

Ranbaxy's anti-malaria molecule enters Phase III clinical trial

06 May 2009

Jubilant signs research deal with Anglo-Swedish firm AstraZeneca

06 May 2009

Ranbaxy recalls Nitrofurantoin capsules in the US

02 May 2009

Wockhardt settles patent row with Orion Corporation

29 Apr 2009

WHO worried over drug-resistant malaria strain

25 Apr 2009

Cipla feels FDA heat: nine ‘deviations’ found

20 Apr 2009

Natco, Dr Reddy’s tie up for cancer generics

16 Apr 2009

Pharmacy benefits manager Express Scripts buys peer NextRx for $4.68 billion

14 Apr 2009

Indian drug pricing regulator to launch national media campaign

14 Apr 2009

The National Pharmaceutical Pricing Authority of India plans to start a nationwide media campaign to create awareness about drug pricing and the availability of lower priced alternatives

Pfizer seeks to increase stake in Indian arm

13 Apr 2009

The world’s biggest drugmaker, US-based Pfizer Inc, yesterday oferred to pay about $136 million (Rs680 crore) to boost its stake in its Indian arm Pfizer Ltd 75 per cent

FDA nod for Stride Arcolabs’ AIDS drug combo

11 Apr 2009

Lupin, Natco team up for generic launch of Shire's `Fosrenol'

09 Apr 2009